Public Holidays Venue Opening Hours
|
|
|
- Adam Alexander
- 5 years ago
- Views:
Transcription
1 Public Holidays Venue Opening Hours Trading Venues that are operated from the United Kingdom follow the UK s public holiday calendar. Exceptions are detailed in this document. May 1st May 7th May 28th August 27th December 25th December 26th January 1st Venue Segment Open Close Open Close Open Close Open Close Open Close Open Close Open Close ICAP Securiti es OTF OTF - Corporate Bonds & Securitised Debt OTF - Credit OTF - Equity OTF - FX OTF - Government Bonds (ex Gilts) OTF - Interest Rate OTF - Money Market Instruments 06:00 18:30 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed 06:00 18:30 07:30 18:30 06:00 18:30 07:00 18:30 Closed Closed Closed Closed Closed Closed 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed 06:00 18:30 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed 06:00 18:30 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed 07:00 18:00 07:00 18:00 07:00 18:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Please contact the Venue Operator with any specific queries, ISLOTFOperator@tpicap.com. Version 1.3, Effective: 21 st December
2 Public Holidays Desk Specific Opens May 1st May 7th May 28th August 27th December 25th August 27th January 1st Desk Open Closed Open Closed Open Closed Open Closed Open Closed Open Closed Open Closed Commercial & 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Local Authority Corporate FRN Closed Closed 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Institutional Sales Closed Closed 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Money Market Closed Closed 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Snr Fin FRN Closed Closed 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Sovereign, Closed Closed 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Closed Closed Supranational and agency Debt (SSA)/ Covered bonds Bank Capital 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed CDS Index 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed EM Bonds & CDS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Equity Finance 06:00 18:30 07:30 18:00 07:30 18:00 08:00 18:30 Closed Closed Closed Closed Closed Closed Eurostoxx 06:00 18:30 08:00 16:00 08:00 16:00 08:00 16:30 Closed Closed Closed Closed Closed Closed Eurostoxx 06:00 18:30 08:00 16:00 08:00 16:00 08:00 16:30 Closed Closed Closed Closed Closed Closed Options Exotics 06:00 18:30 08:00 17:00 08:00 17:00 08:00 17:00 Closed Closed Closed Closed Closed Closed FTSE 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed High Yield 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Corporate HY CDS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed IG Corps 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Version 1.3, Effective: 21 st December
3 Index Delta 1 (Pan 06:00 18:30 08:00 17:00 06:00 18:30 08:00 17:00 Closed Closed Closed Closed Closed Closed European) New Issues 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed SFPG 06:00 18:30 07:30 18:30 07:30 18:30 08:00 18:00 Closed Closed Closed Closed Closed Closed SMI 06:00 18:30 08:00 16:00 08:00 16:00 Closed Closed Closed Closed Closed Closed Closed Closed Snr Fin 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Sterling 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Supranationals 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed AUD, NZD IRS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Cross Currency 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Basis Swaps Euro Medium 06:00 18:30 07:00 17:00 07:00 17:00 07:00 17:00 Closed Closed Closed Closed Closed Closed Term Euro Short Term 06:00 18:30 07:00 17:00 07:00 17:00 07:00 17:00 Closed Closed Closed Closed Closed Closed ICAP Gilts 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Inflation Swaps 06:00 18:30 07:00 17:00 07:00 17:00 07:00 17:00 Closed Closed Closed Closed Closed Closed Interest Rate 06:00 18:30 07:00 17:00 07:00 17:00 07:00 17:00 Closed Closed Closed Closed Closed Closed Options Scandi Desk Closed Closed 08:00 15:00 08:00 15:00 08:00 15:00 Closed Closed Closed Closed Closed Closed Sterling IRS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed (Medium) Sterling IRS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed (Short) USD Medium and 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Short term IRS (not including IGDL) Yen IRS 06:00 18:30 Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed Closed African Currency 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Version 1.3, Effective: 21 st December
4 African 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed (Bonds) Asian 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Cash Desks 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed CE3 MIRS (C4 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Rates ) CNH 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed EM 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Forward 07:00 18:00 07:00 18:00 Closed Closed 07:00 18:00 Closed Closed Closed Closed Closed Closed AUD,NZ,CAD Forward 07:00 18:00 07:00 18:00 Closed Closed 07:00 18:00 Closed Closed Closed Closed Closed Closed AUS/CAD/NZD Forward Euro 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Forward Sterling 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Forward Swiss 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Forward Yen 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Hungarian 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Israeli 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Israeli 07:00 18:00 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Romanian 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed SA Swaps Closed Closed 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Short End 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed PLN/CZK Short End Turkish Closed Closed 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Swiss 07:00 18:00 07:00 18:00 07:00 18:00 07:00 18:00 Closed Closed Closed Closed Closed Closed Turkish IR Closed Closed 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Closed Closed ZAR Bonds Closed Closed 07:00 14:00 07:00 14:00 07:00 14:00 Closed Closed Closed Closed Closed Closed Version 1.3, Effective: 21 st December
5 FX FORWARD + 08:00 18:00 08:00 18:00 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed DEPO DESK (Desk in Copenhagen) Fx Fwd+Deposit Closed Closed 08:00 18:00 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Scandi IRS (Desk at Copenhagen) 08:00 18:00 08:00 18:00 08:00 18:00 08:00 18:00 Closed Closed Closed Closed Closed Closed Version 1.3, Effective: 21 st December
FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009
FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)
Global Banknote Market Report: 2012 Edition. October 2012
Global Banknote Market Report: 2012 Edition October 2012 Executive Summary Moving from barter to currency, the introduction of banknotes was the landmark development which enabled the growth of trade and
Consolidated: Financial Summary
FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating
ELICA 2012 Q3 RESULTS. November 14,
ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation
Fund Performance Bulletin
Fund Performance Bulletin July 7, 2009 July 7, 2009 Page of 0 PATHFINDER B20 Hansard Pathfinder UK 29/0/99.072.8-2.99 -.42-4.8-20.77 2.8 N/A 7.20 0.72 C20 Hansard Pathfinder America /2/98 0.849 0.97-4.0
(Please check against delivery) EMBARGOED FOR 20 APRIL 2017 AT 0900 EST/1500 CET. Ladies and gentlemen,
The European Stability Mechanism - A firewall for the eurozone and first line of defense for global financial stability Klaus Regling, ESM Managing Director Washington DC, 20 April 2017 (Please check against
Group financial results for the first quarter 2008
Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly
1. Legal/business importance parameter: High 2. Market implementation efforts parameter: Low
General Information (Origin of Request) User Requirements (URD) Other User Functional or Technical Documentation (SYS) Request raised by: XMAP Institute: ECB Date raised: 29/06/2015 Request title:, Settlement
1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
Fund Performance Bulletin
Fund Performance Bulletin September 22, 2009 September 22, 2009 Page of 0 PATHFINDER B20 Hansard Pathfinder UK 29/0/99.2.. 27..9-8.4 7.82 N/A 2.0 2.9 C20 Hansard Pathfinder America /2/98 0.974.02.8 2.24-2.
Fund Performance Bulletin
Fund Performance Bulletin March 2, 200 March 2, 200 Page of 0 PATHFINDER B20 Hansard Pathfinder UK 29/0/99..444.97.. -2.4.77 27.00.0 2.82 C20 Hansard Pathfinder America /2/98.0. 4. 7.9 7. -20.44-4.89-2.42
Fund Performance Bulletin
Fund Performance Bulletin April 29, 200 April 29, 200 Page of s s s 0 s PATHFINDER B20 Hansard Pathfinder UK 29/0/99..44 -.84 7.40 27. -4.2 9.29.20.0 2.80 C20 Hansard Pathfinder America /2/98.07.2 2.28.7.20-2.9-0.4-2.94
BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-
BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest
For personal use only
Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for
DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries
The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The
Endesa 1Q 2017 Results 09/05/2017
Endesa 1Q 2017 Results 09/05/2017 1. Highlights and key financial figures 2. Endesa s performance in 1Q 2017 market context 3. Financial results 4. Final remarks 2 1. Highlights and key financial figures
Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011
Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai
Summary of Results for the First Half of FY2015/3
Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial
Coloplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
May 6, 2008 First Quarter 2008 Results
SWEUB2227319CMDV7 May 6, 28 First Quarter 28 Results 1Q 28: Improved results in a challenging environment Page 2 Strong loan growth at 34.2% yoy Accelerated deposit growth at 31% yoy; improved loans /
DELICA D:5 ACTIVE GEAR 0
DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion
CENTRALE. Monetary. compared. domestic. million.
CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
ThromboGenics Business Update H1 2018
Press release 6 September 2018 Regulated Information ThromboGenics Business Update H1 2018 Positive Topline Results for Diabetic Eye Disease Portfolio Shareholder approval for company name change to Oxurion
Pricing 2018 Personal Banking Pay-As-You-Transact
Pricing 2018 Personal Banking Pay-As-You-Transact 2018 Pricing ACCESS TRANSACT PLUS STUDENT 2018 SILVER 2018 PRESTIGE PRIVATE Administration Management Fee 6.5 45 15 89 90 150 Cheque Book Cheque Book Cover
artnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017
Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of
Getting to Eurobonds by reforming the ESM
https://ftalphaville.ft.com/2017/11/21/2195979/guest-post-getting-to-eurobonds-by-reforming-the-esm/ Getting to Eurobonds by reforming the ESM The following guest post on the European Stability Mechanism
Cochlear Limited Results for the half year ended 31 December 2007
Cochlear Limited Results for the half year ended 31 December 2007 Chris Roberts Chief Executive Officer Neville Mitchell Chief Financial Officer Cochlear Overview Medical device company (~26yr): global
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland
Enel Américas 1Q 2018 results
Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation
Innovative Use of Climate financing Instruments
Innovative Use of Climate financing Instruments Current DBSA Involvement in Climate Finance Activities The Green Fund is managed by the Development of Bank of South Africa (DBSA) on behalf of Department
TELECONFERENCE Q August 2015
TELECONFERENCE Q2 2015 19 August 2015 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.
MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its
To be the partner of choice Straumann
To be the partner of choice Straumann Gilbert Achermann, CEO Helvea Swiss Equities Conference 11 January 2008, Bad Ragaz Table of contents 1. A snapshot of Straumann 2. Financials 3. Markets and opportunities
artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016
Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development
TABLE OF CONTENTS NEWSLETTER/WEB BLURB MONEY SMART WEEK MEDIA FACT SHEET MEDIA ALERT Page 2 12
MEDIA KIT 2018 TABLE OF CONTENTS PHOTOGRAPHS AND USE OF PHOTOGRAPHS... 3 BEFORE YOUR MONEY SMART WEEK EVENT... 3 MEDIA RELATIONS TIPS... 3 BEFORE YOU CONTACT MEDIA... 3 WHO TO CONTACT... 3 HOW TO CONTACT
Investor Presentation May 2, 2017
CSE: TBP OTC: GRPOF Investor Presentation May 2, 2017 Forward Looking Statements This presentation contains certain forward-looking statements that may involve a number of risks and uncertainties. Actual
Being the partner of choice. Beat Spalinger, CEO & President presenting at the 2011 Berenberg European conference
Being the partner of choice Beat Spalinger, CEO & President presenting at the 2011 Berenberg European conference Disclaimer This presentation contains certain forward-looking statements, which can be identified
For personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators
Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators José Antonio Izazola Chief, AIDS Financing and Economics Division Evidence, Monitoring and Policy Department UNAIDS Assessment 6.3
ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011
ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE
Economic Valuation of FES and approaches to payments for FES in Germany
Economic Valuation of FES and approaches to payments for FES in Germany Thünen-Institute for International Forestry and Forest Economics, Hamburg Overview 1. Preliminary consideration: What are economic
AP Macroeconomics Schedule Fall 2016
Date Topic & Content In Class For Homework 8/22 Welcome and Introduction to Read Module 1 Syllabus 8/23 The Study of Economics Build a Zoo 8/24 The Study of Economics Economic Concepts Read Module 2 8/25
Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division
Post-2015: Innovative Financing of HIV/AIDS Travis Mitchell Economic Affairs Division High Burden (HIV/AIDS) Low Income countries will remain dependent on external funding for decades, creating major financial
Sunesis Pharmaceuticals Reports Second Quarter 2011 Financial Results
Investor and Media Inquiries: David Pitts Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717 Sunesis Pharmaceuticals Reports Second Quarter 2011 Financial Results SOUTH
ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate
ESM Pricing Policy Objective When granting stability support, the ESM shall aim to fully cover its financing and operating costs and shall include an appropriate margin (Art. 20 of the Treaty). The main
Third-quarter results 2013
Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen
Legal framework for the development of commodity based financing. Krassimir Kiriakov International WHR Expert
Legal framework for the development of commodity based financing Krassimir Kiriakov International WHR Expert Goal and Objectives of the WHR system Goal :To enable cooperation among the government, financial
January 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
Saving lives through immunisation A Corporate Social Responsibility approach
Saving lives through immunisation A Corporate Social Responsibility approach Joelle Tanguy, Managing Director, External Relations, GAVI Alliance (Global Alliance for Vaccines and Immunisation) International
1Q 2014 Earnings Release
1Q 2014 Earnings Release April 2014 DISCLAIMER Financial results for 1Q 2014 are provisional and accordingly subject to change according to the outside independent auditors review. This presentation contains
TELECONFERENCE Q November 2015
TELECONFERENCE Q3 2015 4 November 2015 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
Ellex Medical Lasers (ASX: ELX)
Ellex Medical Lasers (ASX: ELX) Investor Presentation for Year End 30 June 2012 (prepared 31 August 2012) Tom Spurling, Chief Executive 82 Gilbert Street, Adelaide, Australia Phone +61 8 8104 5200 tspurling@ellex.com
MARCH 2014 RESULTS PRESENTATION Madrid, 2014
MARCH 2014 RESULTS PRESENTATION Madrid, 2014 Disclaimer In addition to figures prepared in accordance with IFRS, PRISA presents non-gaap financial performance measures, e.g., EBITDA, EBITDA margin, adjusted
Interim Report 1 January September 2017
2014-01-01 2014-12 Interim Report 1 January 2017 30 September 2017 Cantargia AB 556791-6019 Cantargia refers to Cantargia AB (publ), corporate ID number 556791-6019. Clinical trial initiated Highlights
SWEDISH MATCH RESULTS PRESENTATION Q3 2017
SWEDISH MATCH RESULTS PRESENTATION Q3 2017 DISCLAIMER The information contained in this presentation has not been independently verified and is subject to change without notice and neither Swedish Match,
Calliditas Therapeutics Q2 Report Webcast August 16, 2018, 10:00 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO
Calliditas Therapeutics Q2 Report 2018 Webcast August 16, 2018, 10:00 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO Disclaimer Important information This presentation may contain certain
COMMUNITY FUNDRAISING TOOLKIT
COMMUNITY FUNDRAISING TOOLKIT WELCOME AND THANK YOU Whether you are grateful for the care you or your family has received from Michigan Medicine or you re passionate about curing a disease that has affected
SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )
SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the
Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors
Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, 2014 András Tövisi Chairman of the Board of Directors Philip Morris ČR a.s. Annual General Meeting of Shareholders 2014
Q Investor Kit January December 2015
Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local
European Stability Mechanism Guideline on Precautionary Financial Assistance
European Stability Mechanism Guideline on Precautionary Financial Assistance Article 1 Aim and scope The objective of precautionary financial assistance is to support sound policies and prevent crisis
Russia Cardiac Assist Devices Market Outlook to 2021
Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for
Innovative Finance Update
This document updates the GAVI Alliance Board on the goals, role and progress of GAVI s Innovative Finance team. It outlines the structure and achievements of GAVI s two existing landmark Innovative Finance
The power of innovation to save lives
Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.
Welcome to the Nine-Month Sales Conference
Welcome to the Nine-Month Sales Conference Nine-Month Sales Conference Paul Bulcke Nestlé CEO Nine-Month Sales Conference Wan Ling Martello Chief Financial Officer Disclaimer This presentation contains
Q Investor Kit January December 2014
Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January
British American Tobacco PLC ADR BTI
Page 1 of 5 Morningstar Analyst Rating. Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 71.15 [-0.19-0.27 % $ 71.14 71.05-71.31
Citibank N.A. Foreign currency Deposit interest rate (% p.a.) Effective date 1 February 2017
Currency Deposit Type Citibank N.A. Foreign currency Deposit interest rate (% p.a.) Effective date 1 February 2017 Resident person ตารางแบบรายงานท 1 Customer Type Non-Resident person Individual Corporate
November 1, 2017 DRAFT FOR PUBLIC COMMENT June Guidance Note for ESS9 Financial Intermediaries
The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The
FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO
FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO DISCLAIMER This document contains certain forward-looking information that is subject toa number of factors that may influence the accuracy of
Singapore Exchange Limited 1Q FY2009 Financial Results
Singapore Exchange Limited 1Q FY2009 Financial Results 15 October 2008 Singapore Exchange 1 1Q FY2009 Financial Performance NPAT fell 35% from record 1Q FY2008 Operating profit flat compared to 4Q FY2008
School of Management, NEW JERSEY INSTITUTE OF TECHNOLOGY Master of Science in Management (MSM)
School of Management, NEW JERSEY INSTITUTE OF TECHNOLOGY Master of Science in Management (MSM) Courses (30 credits) Semester Completed Note Requirement Module I: Core Courses (15 credits) ACCT 615 Management
AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE
THIS NOTICE IS FOR YOUR INFORMATION ONLY. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. Bursa Malaysia Securities Berhad ( Bursa Securities ) takes no responsibility for the contents of this Notice, makes no
ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update
ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase
Global Otoscopes Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Otoscopes Market Professional Survey Report 2016 Global Otoscopes Market Professional Survey Report 2016
Q Investor Kit JANUARY-MARCH 2014
Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco
For personal use only. Investor Briefing. Bayswater, 1 st December 2016
Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists
Coloplast A/S. Investor Presentation 2005/06
Coloplast A/S Investor Presentation 2005/06 2 Coloplast in brief Coloplast s products and services help patients achieve greater independence from medical challenges in 4 areas, ostomy care, urology &
1. The World Bank-GAVI Partnership and the Purpose of the Review
1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective
These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.
Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published
Financial results in line with expectations and important progress of the pipeline
Company Announcement - No. 37 / 2015 Zealand Interim report for H1 2015 (un-audited) Financial results in line with expectations and important progress of the pipeline Growing lixisenatide (Lyxumia ) royalty
HILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
INVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
Time Banks Sarah Bird
Time Banks Sarah Bird Timebanking UK, The Exchange, Brick Row, Stroud GL5 1DF Tel: 01453 750952 Email: sarahb@timebanks.co.uk What is a Time Bank? A time bank encourages people to help one another in the
9M RESULTS 2014 CONFERENCE CALL DR. MATTHIAS SCHROFF, CEO
9M RESULTS 2014 CONFERENCE CALL DR. MATTHIAS SCHROFF, CEO BERLIN, 13 NOVEMBER, 2014 Disclaimer Certain statements in this presentation contain formulations or terms referring to the future or future developments,
Unethical behavior detection and performance of salesmen in organizations
Unethical behavior detection and performance of salesmen in organizations Dr Helena Cooper-Thomas 1. Introduction 2. Theory 3. Case study 1 and 2 4. Results 5. Conclusion Effective vs. ethical sale controversy
Ipsen Acquisition of Clementia Pharmaceuticals. February 25, 2019
Ipsen Acquisition of Clementia Pharmaceuticals February 25, 2019 Disclaimer & Safe Harbor This presentation includes only summary information and does not purport to be comprehensive. Forward-looking statements,
THIRD QUARTER REPORT 2011 (UNAUDITED)
THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor
Disclaimer. Matrix Metals Limited Presentation October
Matrix Metals Limited Presentation October 2008 Disclaimer The material used is this presentation is intended to be a summary of selected geological data, current and proposed activities, as well as resource
Innovative Finance: the power of innovation to save lives
Innovative Finance: the power of innovation to save lives GAVI s mission is to save children s lives and protect people s health by increasing access to immunisation in poor countries. To that end, the
ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update
ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109
Zealand Pharma A/S Interim report for Q (un-audited)
Company Announcement No. 12/2012 (un-audited) Net profit for the quarter of DKK 66 (EUR 9) million Important pipeline progress, and revenue from milestone payments of DKK 120 (EUR 16) million Cash and
Community Fundraising Toolkit
Community Fundraising Toolkit WELCOME AND THANK YOU Whether you are grateful for the care you or your family has received from the University of Michigan Health System (UMHS) or you re passionate about
SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
The Changing Economic Landscape of Africa: Enter China
The Changing Economic Landscape of Africa: Enter China Karanta Kalley Regional Managing Director, Africa Group October 8, 2007 Highlights Recent developments and Outlook Changes in the Economic Landscape
Shareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)